Large-scale genomic surveillance reveals immunosuppression drives mutation dynamics in persistent SARS-CoV-2 infections

Read full text
Authors: Mark P. Khurana, Alexandros Katsiferis, Neil Scheidwasser, Mathilde Marie Brünnich Sloth, Jacob Liam Curran-Sebastian, Christian Morgenstern, Man‐Hung Eric Tang, Jannik Fonager, Morten Rasmussen, Marc Stegger, Sune Lehmann, Charles Whittaker
+8 more Laust Hvas Mortensen, Pikka Jokelainen, Moritz U.G. Kraemer, Neil M. Ferguson, Mahan Ghafari, Tyra Grove Krause, David Alejandro Duchêne, Samir Bhatt
Cited by: 1
References: 91

Abstract

Persistent SARS-CoV-2 infections have been hypothesized to play a key role in the emergence of variants of concern. However, the factors determining which individuals are at risk and their viral molecular signatures during infection remain poorly understood. Using Denmark's extensive COVID-19 surveillance, comprising over 700,000 genomes, we identify 303 persistent infections and, critically, link them to health and sociodemographic data. Our analysis confirms the hypothesis that immunocompromised individuals are at the highest risk of experiencing persistent infections. Other disease groups associated with mortality, such as diabetes, show no such associations. Among these persistent infections, the viral sequences exhibit signs of positive selection, with recurrent mutations linked to treatment resistance. Our findings suggest that immunosuppression plays a key role in the emergence of novelty in persistent infections.

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Evolution and Genetic Dynamics CRISPR and Genetic Engineering

Publication details

Journal / source
Nature Communications
Publisher
Springer Science and Business Media LLC
Volume
17
Issue
1
Publication date
19 June 2026
Language
EN